INS and type 2 diabetes mellitus: Continuous glucose monitoring (CGM) and telemedicine may help optimise glycaemic control in this vulnerable population.<h4>Materials and methods</h4>In order to assess the efficacy and safety of a CGM and telemedicine-based management of insulin therapy in nursing home residents with T2D, a 12-week, randomised, controlled and open-label trial has been designed.